Monique Roobol

Tumour characteristics and patient profile: Crucial issues in PCa treatment

Despite advances in diagnostic tools and imaging technologies, prostate cancer (PCa) management remains a challenge to many experts due to extensive variability in tumour characteristics and individual patient profiles which complicate the delivery of an optimal treatment plan. “There...

ESO conference tackles thorny prostate cancer issues

Controversial issues such as prostate cancer screening and the changing role of surgery in advanced diseased were discussed in the opening plenary session of the European School of Oncology (ESO) with experts acknowledging the role of timely screening while...

6th EMUC: Active surveillance in PCa, a temporary but indispensable solution

With the concern regarding over-diagnosis and unnecessary treatment in indolent prostate cancer, the option to choose active surveillance (AS) has become a clear fallback position and experts say this may well be the case so long as the concern...

Dutch expert: PSA screening is here to stay despite debate

Despite the continuing debate regarding the harms and benefits of PSA screening, prostate cancer experts from the Netherlands are convinced that PSA screening “is here to stay.” We are now at a stage where we acknowledge the existence of...

Prostate Cancer Risk Calculator offers men ‘individual risk assessment’

Men worried about prostate cancer have a new online resource, freely available, to help them assess their risk. The multi-step Prostate Cancer Risk Calculator, launched yesterday, 17 May 2012, has been created by the founders of the European Randomized...